ArticlePharmacoEconomics - open2020

Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK.

Bernd Schweikert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.